QA: Clovis Oncology Inc in us_pharma/2018

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001466301_2019_Clovis_Oncology_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001466301, Clovis Oncology Inc

  xvar xval
0 AssetsCurrent 572,299,000
1 IntangibleAssetsNetIncludingGoodwill 115,004,000
2 PropertyPlantAndEquipmentNet 26,524,000
3 remainder_Assets 149,733,000
4 LiabilitiesCurrent 125,749,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 591,342,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 192,928,911
9 ResearchAndDevelopmentExpense 203,545,930
10 remainder_Expenses 18,156,996
11 remainder_Revenues 178,300,409
12 remainder_NetIncome -72,124,866
13 remainder_ComprehensiveNetIncome -1,869,573
  yvar yval
0 Assets 863,560,000
1 Liabilities 717,091,000
2 Expenses 414,631,837
3 Revenues 178,300,409
4 StockholdersEquity 146,469,000
5 NetIncome -308,456,294
6 ComprehensiveNetIncome -309,391,080
7 BaseVar 1,123,788,842
8 EconomicCapitalRatiobeforeLimitedLiability 0.0125
9 EconomicCapitalRatio 1.42

Edgar->Model Mapping

Feature Distribution

Change over Time